Navigation Links
Femtogram Sensitivity of the Antipsychotic Drugs Raclopride and Ritanserin Using a Varian 1200L LC/MS/MS

J. Beck and C. Schmidt
Varian, Inc.

Introduction

Ritanserin (Tisterton) is a serotonin-2 antagonist drug shown to be effective in the treatment of anxiety and depression1 while Raclopride acts as a dopamine D2 receptor antagonist.2 These two compounds were used to demonstrate low-level sensitivity of the Varian 1200L LC/MS/MS in selected reaction monitoring mode (SRM). Studies have shown LC/MS to be a useful tool in the quantitation of low levels of Raclopride.3

Instrumentation

Varian 1200L LC/MS/MS equipped with ESI source

Materials and Reagents

Ritanserin ordered from Sigma-Aldrich Corp.,Catalog Number R-103

S-(-)-Raclopride ordered from Sigma-Aldrich Corp.,Catalog Number R-121

All other chemicals are reagent grade or HPLC grade

Sample Preparation

Milligram quantities were prepared and dissolved in a 50:50 mixture of acetonitrile/water with 0.1% formic acid. Serial dilutions were made from each stock solution prior to flow injection analysis (FIA). Samples were injected into a mobile phase of 50:50 acetonitrile/0.1% formic acid which was pumped directly into the mass spectrometer at 0.2 mL/min. A 5 μL loop was used for the injections and the injections were repeated five times for each concentration level.

Results and Discussion

Raclopride Five replicates at five different concentration levels were run. FIA injections of Raclopride at its lowest detectable limit, 100 pg/mL (500 fg on-column), is shown in Figure 1. At the lowest level, the S/N ratio is approximately 10:1 for the raw data. Also, a plot at a higher concentration of 10 ng/mL is included for comparison (Figure 2). The calibration cur ve in Figure 3 shows the average area of the five replicates plotted against the amount injected.

Ritanserin Five replicates at five different concentration levels were run. FIA injections of Ritanserin at its lowest detectable limit, 10 pg/mL (50 fg on-column), is shown in Figure 4. At a concentration 10 times lower than Raclopride, Ritanserin is easily detected. With a S/N ratio of more than 20:1 at 10 pg/mL, it should be possible to achieve even lower limits of detection for Ritanserin.

Conclusion

The ability to accurately detect low levels of analytes is an essential requirement for many pharmaceutical, toxicological, and clinical applications. The data presented in this application note illustrates that the Varian 1200L triple quadrupole mass spectrometer is capable of achieving very reproducible results at femtogram levels for compounds such as Ritanserin and Raclopride.

References

1. http://www.books.md/R/dic/ritanserin.php

2. http://www.online-medical-dictionary.org/?q=Raclopride

3. Forngren, B.H. Liquid Chromatography-Mass Spectrometry in the Analysis of Radiolabelled Compounds for Positron Emission Tomography. Acta Universitaris Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 586. 56pp. Uppsala. ISBN 91-554-4810-0


'"/>

Source:


Page: All 1 2

Related biology technology :

1. Improved Sensitivity for Staining RNA with SYBR Gold Stain
2. Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep Technology
3. Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase
4. Increased Sensitivity in Microarray Analysis
5. Maintaining High Sensitivity when Working with Small-Volume Samples
6. High Sensitivity, Wide Dynamic Range, Horseradish Peroxidase (HRP) ELISA Using the LMax Microplate Luminometer (MaxLine Application Note #41)
7. Sensitivity and Quantitation using a Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer
8. Increased Analyte Sensitivity through the Utility of Enhanced Mass-Resolution on the FinniganTSQ Quantum Discovery
9. Trace Analysis Optimizing Sensitivity Finnigan Surveyor PDA Detector
10. A Screen of shRNAs Targeting Tumor Suppressor Genes to Identify Factors Involved in Paclitaxel Sensitivity
11. Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):